Monitoring gastric cancer progression with circulating tumour DNA

British Journal of Cancer

Volumn 112, Issue 2, 2015, Pages 352-356

  Hamakawa, T ^a,b   Kukita, Y ^b   Kurokawa, Y ^a   Miyazaki, Y ^a   Takahashi, T ^a   Yamasaki, M ^a   Miyata, H ^a   Nakajima, K ^a   Taniguchi, K ^b   Takiguchi, S ^a   Mori, M ^a   Doki, Y ^a   Kato, K ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Circulating tumour DNA; Deep sequencing; Gastric cancer; Next generation sequencing

Indexed keywords

CHLOROPLAST DNA; CIRCULATING TUMOR DNA; DNA; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PROTEIN P53; TRASTUZUMAB; UNCLASSIFIED DRUG; TP53 PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER TISSUE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DISEASE COURSE; FBXW7 GENE; FOLLOW UP; GASTRECTOMY; GENE SEQUENCE; GENETIC TRAIT; HUMAN; HUMAN TISSUE; LEUKOCYTE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PIK3CA GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOMATIC MUTATION; STOMACH CANCER; TREATMENT RESPONSE; TUMOR GENE; VERY ELDERLY; BLOOD; GENETICS; HIGH THROUGHPUT SEQUENCING; MINIMAL RESIDUAL DISEASE; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH NEOPLASMS;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM, RESIDUAL; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84921939213     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.609     Document Type: Article

References (13)

1. Dawson S-J, Tsui DWY, Murtaza M, Biggs H, Rueda OM, Chin S-F, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368(13): 1199-1209.
2. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz Jr LA (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14(9): 985-990.
3. Dressman D, Yan H, Traverso G, Kinzler KW, Vogelstein B (2003) Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci USA 100(15): 8817-8822.
4. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2): 228-247.
5. Junemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, Mellmann A, Goesmann A, von Haeseler A, Stoye J, Harmsen D (2013) Updating benchtop sequencing performance comparison. Nat Biotechnol 31(4): 294-296.
6. Kolesnikova EV, Tamkovich SN, Bryzgunova OE, Shelestyuk PI, Permyakova VI, Vlassov VV, Tuzikov AS, Laktionov PP, Rykova EY (2008) Circulating DNA in the blood of gastric cancer patients. Ann N Y Acad Sci 1137: 226-231.
7. Kukita Y, Uchida J, Oba S, Nishino K, Kumagai T, Taniguchi K, Okuyama T, Imamura F, Kato K (2013) Quantitative Identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data. PloS One 8(11): e81468.
8. Park JL, Kim HJ, Choi BY, Lee HC, Jang HR, Song KS, Noh SM, Kim SY, Han DS, Kim YS (2012) Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients. Oncol Lett 3(4): 921-926.
9. Park KU, Lee HE, Park do J, Jung EJ, Song J, Kim HH, Choe G, Kim WH, Lee HS (2009) MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis. Clin Chem Lab Med 47(5): 530-536.
10. Rago C, Huso DL, Diehl F, Karim B, Liu G, Papadopoulos N, Samuels Y, Velculescu VE, Vogelstein B, Kinzler KW, Diaz LA Jr (2007) Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res 67(19): 9364-9370.
11. Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11(6): 426-437.
12. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y (2013) Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17(1): 26-33.
13. Tie J, Kinde I, Wang Y, Vogelstein B, Gibbs P (2014) Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC). J Clin Oncol 32(suppl 5s): abstr 11015.